Marksans Pharma Limited
NSE: MARKSANS | Information Technology
Market Fundamentals
Stock Intelligence & News
Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange about Schedule of conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026 |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Marksans Pharma Limited
Board Meeting Intimation |Meeting Date: 26-May-2026
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Marksans Pharma Limited
Financial Results/Dividend |Meeting Date: 26-May-2026
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "USFDA approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx)". |SUBJECT: Press Release
Read Full Analysis →Marksans Pharma Limited
MARKSANS PHARMA LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange about Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Marksans Pharma Limited
Marksans Pharma Limited has informed the Exchange about its Official's participation in Investec India Promoter & Founder conference 2026 |SUBJECT: General Updates
Read Full Analysis →Get instant alerts when MARKSANS breaks news
Join investors who track Marksans Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for MARKSANS?
MARKSANS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Marksans Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding MARKSANS to your custom watchlist.